Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

FDA approves return of morning sickness drug for pregnant women

Regulator confirms safety of Diclegis – formerly known as Bendectin

- PMLiVE

Tamiflu sales boost Roche results despite efficacy concerns

Pharma company reports total sales of $12.44bn in first quarter of 2013

- PMLiVE

First efficacy data for GSK/Prosensa’s muscular dystrophy candidate positive

Ups ante in race against Sarepta Therapeutics to market first Duchenne muscular dystrophy drug

- PMLiVE

PAN promotes Julia Straker to board of directors

Becomes director of strategic brand planning

Coulter Partners expands North American team

Madeline Barrett and Nancy McCloskey join New Jersey office

- PMLiVE

Additional NICE recommendation for Novartis’ Lucentis

Says drug can be used in patients with macular oedema caused by blockage of the veins in the retina

- PMLiVE

US-based Millennium launches blood cancer website

The Takeda Oncology Company roll out new multiple myeloma website

- PMLiVE

3 Monkeys launch healthcare practice

Agency hires Dr Martin Godfrey to lead the new division

- PMLiVE

Clinical trials for EMA-submitted medicines move away from US and Europe

Most trial patients for drug marketing applications to EMA now come from rest of the world

- PMLiVE

Gilead files oral hepatitis C drug sofosbuvir in US

Could be part of first all-oral regimen for virus

- PMLiVE

Alkermes cuts jobs in Ireland as Novartis invests

130 jobs to go at manufacturing facility in Athlone as Novartis creates 100 roles in Dublin

- PMLiVE

Teva appoints Lilly directors to CEO positions in Asia

Yoo Suk Hong named CEO of Teva-Handok and Ichiro Kikushige named CEO of Teva Seiyaku

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links